| 摘要 |
COMPOUNDS OF FORMULA 1 IN FREE OR SALT FORM, WHEREIN RA,RB,R2,R3,R4 AND R5 HAVE THE MEANINGS AS INDICATED IN THE SPECIFICATION, ARE USEFUL FOR TREATING CONDITIONS THAT ARE MEDIATED BY MEDIATED BY PHOSPHATIDYLINOSITOL 3-KINASE. PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THE COMPOUNDS AND A PROCESS FOR PREPARING THE COMPOUNDS ARE ALSO DESCRIBED.
|
